Secondary endpoints included objective response rate, one-year survival rate, overall survival, PFS assessment by chemotherapy type and safety.
二级终点包含了目标反应率，一年生存期，总生存率，化疗类型和安全性PFS评估。
The study found that the one-year survival rate was 89 percent for those who got older blood, but nearly 93 percent for patients who got fresher blood.
研究发现一年后病人的存活率在输入存放时间较长血液的病人组中是89%，在另一组中93%。
The follow-up was 3-43 month after the operation. The one year and three years survival rate were 98% (47/48) and 91% (20/22) .
术后随访时间3-43个月，1、3年生存率分别为98%（47/48）和91%（20/22），2例患者局部复发，2例患者肝转移，术后因肿瘤转移死亡2例，失访3例；
The follow-up was 3-43 month after the operation. The one year and three years survival rate were 98% (47/48) and 91% (20/22) .
术后随访时间3-43个月，1、3年生存率分别为98%（47/48）和91%（20/22），2例患者局部复发，2例患者肝转移，术后因肿瘤转移死亡2例，失访3例；
应用推荐